GABA is a major inhibitory neurotransmitter that helps regulate the timing and coordination of neural activity. Glutamate can activate GABA-producing interneurons, so reduced activity at an excitatory receptor may sometimes lead to less inhibition elsewhere. This illustrates why network effects cannot be inferred simply from whether a transmitter is called excitatory or inhibitory.
Glutamate is the brain’s principal excitatory neurotransmitter and is involved in learning, plasticity and communication across neural networks. It acts through several receptor types with different properties. Its normal role is essential, and a glutamate hypothesis of schizophrenia does not imply that ordinary dietary glutamate directly causes the illness.
Schizophrenia research examines interneurons, oscillations and excitation–inhibition relationships in cognition and perception. Findings are complex and do not establish one imbalance shared by every person. Directly changing one transmitter may have widespread consequences, which complicates treatment development. The interaction helps explain why glutamate, GABA and dopamine hypotheses can overlap. It should be presented as a framework for investigating circuits, not as proof that a particular symptom has a single cause or that a supplement can restore an assumed balance.
Inhibitory circuits help coordinate when neurons fire, rather than merely reducing all activity. Disturbing that timing may affect information processing even when average activity appears similar. Excitation–inhibition models therefore examine organisation as well as amount. They offer a way to connect transmitter research with cognition while leaving open which mechanisms are most relevant to different people and symptom patterns.
Further reading: Research record 31299229.
Comments are closed, but trackbacks and pingbacks are open.